Yuqi Shang
Hohhot, 010017, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dapagliflozin May Attenuate Podocyte Injury in Diabetic Kidney Disease through Inhibition of Lactate-Mediated H4K12 Lactylation.
Journal: Kidney & blood pressure research
Published: January 08, 2026
Efficacy and safety of insulin sensitisers for treating type 2 diabetes: a network meta-analysis.
Journal: European journal of clinical pharmacology
Published: April 16, 2025
Cost-effectiveness analysis of lorlatinib and crizotinib in the first-line treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: November 07, 2024
GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3.
Journal: Cellular & molecular immunology
Published: November 03, 2023
Plasma exchange plus glucocorticoids in the treatment of immune checkpoint inhibitor-induced myocarditis: A case series and review.
Journal: Clinical cardiology
Published: June 03, 2023
Leukocyte Immunoglobulin-like Receptor A5 Deletion Aggravates the Pathogenesis of Pseudomonas aeruginosa Keratitis by Promoting Proinflammatory Cytokines.
Journal: Cornea
Published: August 19, 2022
OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer.
Journal: International immunopharmacology
Published: December 12, 2021
TARM-1 Is Critical for Macrophage Activation and Th1 Response in Mycobacterium tuberculosis Infection.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 09, 2020
Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients.
Journal: Frontiers in immunology
Published: July 07, 2020
Signaling Lymphocytic Activation Molecule Family-7 Alleviates Corneal Inflammation by Promoting M2 Polarization.
Journal: The Journal of infectious diseases
Published: April 30, 2020
Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study.
Journal: Trials
Published: February 29, 2020
Last Updated: 09/26/2026